*Zaberunnisa, Dr. M. Vijaya Bhargavi, Nagma Begum and Dr. M. Sumakanth


Over the last three decades, the tremendous claim for the financial success of biopharmaceutical products have seen the accessible switch for close copies of these biological product (biosimilars). Biologics is considered as one of the fastest growing sectors of the pharmaceutical industry, whereas a biosimilar is formally organized and approved replica of an originator biologic therapies. As the use of biological therapies expands, the number and diversity of induced autoimmune disorders should be expected to increase. The expiry of patent protection for many biological medicines has led to the development of biosimilars in UK or follow on biologics in USA. More specifically, the overarching aims of this article were to review the current issues revolving around biosimilar and take a critical glance related to definition; types of biosimilars, biosimilars differ from generic drugs, focusing/clinical standards on safety and efficacy, potential impact on financial burden in healthcare and future prospects of biosimilars in India, Europe and the rest of the world.

Keywords: Biopharmaceutical products, biologics, biological products, generic drugs, auto-immune disorders, safety and efficacy.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    MARCH 2021 Issue has been successfully launched on 1 March 2021.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction